Significant Association Between Low Baseline Neutrophil-To-Lymphocyte Ratio and Improved Progression-Free Survival of Patients With Locally Advanced or Metastatic Breast Cancers Treated With Eribulin but Not With Nab-Paclitaxel
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2018.03.002
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV